BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 278 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2021. The put-call ratio across all filers is 1.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $518,000 | -61.2% | 4,839 | -62.8% | 0.02% | -57.1% |
| Q3 2021 | $1,336,000 | +18.3% | 12,994 | +1.2% | 0.04% | +55.6% |
| Q2 2021 | $1,129,000 | -20.1% | 12,836 | -11.7% | 0.03% | -20.6% |
| Q1 2021 | $1,413,000 | -15.6% | 14,529 | -2.7% | 0.03% | -5.6% |
| Q4 2020 | $1,674,000 | +265.5% | 14,925 | +160.7% | 0.04% | +260.0% |
| Q1 2019 | $458,000 | +48.2% | 5,725 | 0.0% | 0.01% | +25.0% |
| Q4 2018 | $309,000 | -30.9% | 5,725 | 0.0% | 0.01% | -20.0% |
| Q3 2018 | $447,000 | -42.7% | 5,725 | -53.4% | 0.01% | -44.4% |
| Q2 2018 | $780,000 | -30.8% | 12,285 | 0.0% | 0.02% | -33.3% |
| Q1 2018 | $1,127,000 | +79.5% | 12,285 | +47.5% | 0.03% | +92.9% |
| Q4 2017 | $628,000 | +8.3% | 8,330 | 0.0% | 0.01% | +7.7% |
| Q3 2017 | $580,000 | +37.4% | 8,330 | 0.0% | 0.01% | +44.4% |
| Q2 2017 | $422,000 | – | 8,330 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 581,768 | $25,487,256 | 9.57% |
| Casdin Capital, LLC | 1,477,800 | $64,742,418 | 5.02% |
| Nextech Invest Ltd. | 188,228 | $8,246,269 | 3.28% |
| DAFNA Capital Management LLC | 261,235 | $11,444,705 | 3.22% |
| Rock Springs Capital Management LP | 1,891,510 | $82,867,053 | 1.99% |
| HealthCor Management, L.P. | 30,000 | $1,314,300 | 1.20% |
| EFG Asset Management (North America) Corp. | 110,853 | $4,766,679 | 1.07% |
| Novo Holdings A/S | 370,000 | $16,209,700 | 1.01% |
| SECTORAL ASSET MANAGEMENT INC | 115,900 | $5,077,579 | 0.98% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 305,709 | $13,393,111 | 0.83% |